4-(7-(4-((Benzyloxy)carbonyl)piperazin-1-yl)-4,4-dimethyl-8-nitrochromeno[4,3-c]pyrazol-1(4H)-yl)benzoic acid
99%
- Product Code: 46383
CAS:
2024548-03-4
| Molecular Weight: | 583.5913 g./mol | Molecular Formula: | C₃₁H₂₉N₅O₇ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. Its structure, featuring a chromenopyrazole core, makes it a valuable intermediate in designing molecules with potential biological activity. It is often explored for its role in targeting specific enzymes or receptors involved in diseases such as cancer, inflammation, or neurological disorders. Researchers also investigate its potential as a building block for developing inhibitors or modulators of protein-protein interactions. Additionally, its nitro and carboxyl groups provide sites for further chemical modifications, enabling the creation of derivatives with enhanced pharmacological properties.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.050 | 10-20 days | $941.58 |
+
-
|
4-(7-(4-((Benzyloxy)carbonyl)piperazin-1-yl)-4,4-dimethyl-8-nitrochromeno[4,3-c]pyrazol-1(4H)-yl)benzoic acid
This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. Its structure, featuring a chromenopyrazole core, makes it a valuable intermediate in designing molecules with potential biological activity. It is often explored for its role in targeting specific enzymes or receptors involved in diseases such as cancer, inflammation, or neurological disorders. Researchers also investigate its potential as a building block for developing inhibitors or modulators of protein-protein interactions. Additionally, its nitro and carboxyl groups provide sites for further chemical modifications, enabling the creation of derivatives with enhanced pharmacological properties.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :